PaxMedica, Inc. Common Stock (PXMD)
USD 0.08
(0.0%)
USD 0.08
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -10.76 Million | -6.07 Million | -5.51 Million | -2.34 Million | -419.37 Thousand |
| Net Income | -18.28 Million | -14.8 Million | -10.22 Million | -7.82 Million | -598.6 Thousand |
| Depreciation & Amortization | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | 5.2 Million | 4.41 Million | 1.33 Million | 2.26 Million | - |
| Change in working capital | 333.84 Thousand | 50.34 Thousand | 351.72 Thousand | 961.88 Thousand | 116.64 Thousand |
| Other non-cash items | 1.98 Million | 4.26 Million | 3.02 Million | 2.25 Million | 62.58 Thousand |
| Investing Cash Flow | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - |
| Acquisitions | - | - | - | - | - |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - |
| Financing Cash Flow | 13.57 Million | 7.52 Million | 4.83 Million | 3.44 Million | 435 Thousand |
| Debt repayment | -2.45 Million | -1.24 Million | - | -2.92 Million | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | -195.99 Thousand | -35 Thousand | - | - | - |
| Common Stock Issuance | 11.44 Million | 6.02 Million | 5 Million | - | - |
| Other Financing Activities | 11.95 Billion | 2.81 Million | -166.89 Thousand | 6.37 Million | 435 Thousand |
| Accounts receivables | - | - | - | - | - |
| Accounts payables | 456.22 Thousand | 114.16 Thousand | 250.22 Thousand | 392.54 Thousand | 53.89 Thousand |
| Inventory | - | - | - | - | - |
| Other working capital | -122.37 Thousand | -63.81 Thousand | 101.5 Thousand | 569.33 Thousand | 62.75 Thousand |
| Cash at beginning of period | 1.9 Million | 444.08 Thousand | 1.12 Million | 24.94 Thousand | 9322.00 |
| Cash at end of period | 4.71 Million | 1.9 Million | 444.08 Thousand | 1.12 Million | 24.94 Thousand |
| Capital Expenditure | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | 2.8 Million | 1.45 Million | -679.53 Thousand | 1.09 Million | 15.62 Thousand |
| Free Cash Flow | -10.76 Million | -6.07 Million | -5.51 Million | -2.34 Million | -419.37 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.99 Million | -3.69 Million | -5.92 Million | -18.28 Million | -5.04 Million | -3.48 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 151.00 | 1.51 Million | 704.77 Thousand | 5.2 Million | 1.06 Million | 1.26 Million |
| Change in working capital | 1.69 Million | -888.68 Thousand | 1.21 Million | 333.84 Thousand | 1.46 Million | -1.23 Million |
| Other non-cash items | 5.17 Million | - | 1.38 Million | 1.98 Million | 183.38 Thousand | 624.42 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | -15.27 Thousand | 6.17 Million | 13.57 Million | 414.86 Thousand | 1.91 Million |
| Debt repayment | - | - | -316.92 Thousand | -2.45 Million | -322 Thousand | -3.7 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | 11.94 Billion | -195.99 Thousand | - | - |
| Common Stock Issuance | - | - | 5.87 Million | 11.44 Million | 795.3 Thousand | 1.96 Million |
| Other Financing Activities | 15.27 Thousand | -15.27 Thousand | 615.55 Thousand | 11.95 Billion | -58.43 Thousand | -45.88 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 904.13 Thousand | 307.73 Thousand | -833.26 Thousand | 456.22 Thousand | 986.28 Thousand | 178.16 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 791.08 Thousand | - | 2.05 Million | -122.37 Thousand | 482.83 Thousand | -1.41 Million |
| Cash at beginning of period | 1.62 Million | 4.71 Million | 1.15 Million | 1.9 Million | 3.06 Million | 3.98 Million |
| Cash at end of period | 324.48 Thousand | 1.62 Million | 4.71 Million | 4.71 Million | 1.15 Million | 3.06 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -1.3 Million | -3.08 Million | 3.55 Million | 2.8 Million | -1.91 Million | -916.35 Thousand |
| Free Cash Flow | -1.3 Million | -3.06 Million | -2.61 Million | -10.76 Million | -2.33 Million | -2.83 Million |
VUK
CIHHF
002765
RKLIF
ICNB
TWL